{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:09:07Z","timestamp":1794953347733,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer is a public health problem worldwide. Taiwan has a higher incidence rate of urological cancers than many Asian countries do. Aristolochic acid has been considered a potent carcinogen. In this study, we examined whether the cessation of the sales and preparation of aristolochic acid-containing Chinese herbal products (AA-CHPs) in Taiwan contributed to a decline in the incidence rates of bladder cancer, carcinomas of the renal pelvis and other urinary organs, and kidney cancer. We conducted an interrupted time-series analysis of long-term trends in the incidence rates of the aforementioned cancers between 1995 and 2013 in Taiwan. The incidence rates of bladder cancer and carcinomas of the renal pelvis and other urinary organs decreased considerably after 2008 and 2011, respectively. Notably, these change-of-slope time points occurred after the year 2003, when a ban on AA-CHPs was imposed in Taiwan. The ban on AA-CHPs in Taiwan was possibly associated with the reduction in the incidence of bladder cancer and carcinomas of the renal pelvis and other urinary organs.<\/jats:p>","DOI":"10.1038\/s41598-019-56394-y","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:03:12Z","timestamp":1577444592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis"],"prefix":"10.1038","volume":"9","author":[{"given":"Jing-Rong","family":"Jhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9195-6897","authenticated-orcid":false,"given":"Shih-Yung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"56394_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386, https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int. J. Cancer"},{"key":"56394_CR2","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jfma.2015.10.011","volume":"115","author":"CJ Chiang","year":"2016","unstructured":"Chiang, C. J. et al. Incidence and survival of adult cancer patients in Taiwan, 2002\u20132012. J. Formos. Med. Assoc. 115, 1076\u20131088, https:\/\/doi.org\/10.1016\/j.jfma.2015.10.011 (2016).","journal-title":"J. Formos. Med. Assoc."},{"key":"56394_CR3","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.7314\/apjcp.2015.16.16.7365","volume":"16","author":"R Pakzad","year":"2015","unstructured":"Pakzad, R. et al. Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia. Asian Pac. J. Cancer Prev. 16, 7365\u20137374, https:\/\/doi.org\/10.7314\/apjcp.2015.16.16.7365 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"56394_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.15171\/jnp.2017.06","volume":"6","author":"M Arabsalmani","year":"2017","unstructured":"Arabsalmani, M. et al. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J. Nephropathol. 6, 30\u201342, https:\/\/doi.org\/10.15171\/jnp.2017.06 (2017).","journal-title":"J. Nephropathol."},{"key":"56394_CR5","unstructured":"International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 82, Lyon, France: International Agency for Research on Cancer (2002)."},{"key":"56394_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrurol.2013.186","volume":"10","author":"M Clyne","year":"2013","unstructured":"Clyne, M. Bladder cancer: aristolochic acid\u2013one of the most potent carcinogens known to man. Nat. Rev. Urol. 10, 552, https:\/\/doi.org\/10.1038\/nrurol.2013.186 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"56394_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","volume":"342","author":"LN Joelle","year":"2000","unstructured":"Joelle, L. N. et al. Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolo chia Fangchi). N. Engl. J. Med. 342, 1686\u20131692, https:\/\/doi.org\/10.1056\/NEJM200006083422301 (2000).","journal-title":"N. Engl. J. Med."},{"key":"56394_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","volume":"18","author":"LN Joelle","year":"2003","unstructured":"Joelle, L. N. et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol. Dial. Transplant 18, 426\u2013428, https:\/\/doi.org\/10.1093\/ndt\/18.2.426 (2003).","journal-title":"Nephrol. Dial. Transplant"},{"key":"56394_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0272-6386(99)70136-8","volume":"33","author":"J-P Cosyns","year":"1999","unstructured":"Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., Wese, F.-X. & van Ypersele de Strihou, C. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 33, 1011\u20131017, https:\/\/doi.org\/10.1016\/s0272-6386(99)70136-8 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"56394_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/jnci\/djp467","volume":"102","author":"MN Lai","year":"2010","unstructured":"Lai, M. N., Wang, S. M., Chen, P. C., Chen, Y. Y. & Wang, J. D. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J. Natl. Cancer Inst. 102, 179\u2013186, https:\/\/doi.org\/10.1093\/jnci\/djp467 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"56394_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/s0140-6736(01)06576-x","volume":"358","author":"GM Lord","year":"2001","unstructured":"Lord, G. M. et al. Urothelial malignant disease and Chinese herbal nephropathy. The Lancet 358, 1515\u20131516, https:\/\/doi.org\/10.1016\/s0140-6736(01)06576-x (2001).","journal-title":"The Lancet"},{"key":"56394_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/0886022X.2014.990347","volume":"37","author":"M Sun","year":"2015","unstructured":"Sun, M. et al. Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China. Ren. Fai.l 37, 209\u2013213, https:\/\/doi.org\/10.3109\/0886022X.2014.990347 (2015).","journal-title":"Ren. Fai.l"},{"key":"56394_CR13","doi-asserted-by":"publisher","first-page":"149750","DOI":"10.1155\/2014\/149750","volume":"2014","author":"SM Wang","year":"2014","unstructured":"Wang, S. M. et al. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997\u20132008. Biomed. Res. Int. 2014, 149750, https:\/\/doi.org\/10.1155\/2014\/149750 (2014).","journal-title":"Biomed. Res. Int."},{"key":"56394_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/1055-9965.EPI-12-1386","volume":"22","author":"F Wu","year":"2013","unstructured":"Wu, F. & Wang, T. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol. Biomarkers Prev. 22, 812\u2013820, https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1386 (2013).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"56394_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.juro.2012.08.090","volume":"189","author":"HY Yang","year":"2013","unstructured":"Yang, H. Y., Wang, J. D., Lo, T. C. & Chen, P. C. Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists. J. Urol. 189, 48\u201352, https:\/\/doi.org\/10.1016\/j.juro.2012.08.090 (2013).","journal-title":"J. Urol."},{"key":"56394_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0929-6646(11)60026-0","volume":"110","author":"H-Y Yang","year":"2011","unstructured":"Yang, H.-Y., Wang, J.-D., Lo, T.-C. & Chen, P.-C. Increased Risks of Upper Tract Urothelial Carcinoma in Male and Female Chinese Herbalists. J. Formos. Med. Assoc. 110, 161\u2013168, https:\/\/doi.org\/10.1016\/s0929-6646(11)60026-0 (2011).","journal-title":"J. Formos. Med. Assoc."},{"key":"56394_CR17","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1073\/pnas.1119920109","volume":"109","author":"CH Chen","year":"2012","unstructured":"Chen, C. H. et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA 109, 8241\u20138246, https:\/\/doi.org\/10.1073\/pnas.1119920109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56394_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/15563650600671712","volume":"44","author":"TP Cheung","year":"2006","unstructured":"Cheung, T. P., Xue, C., Leung, K., Chan, K. & Li, C. G. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products\u2013a consequence of inappropriate nomenclature and imprecise labelling? Clin. Toxicol. (Phila) 44, 371\u2013378, https:\/\/doi.org\/10.1080\/15563650600671712 (2006).","journal-title":"Clin. Toxicol. (Phila)"},{"key":"56394_CR19","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1056\/nejm200006083422309","volume":"342","author":"DA Kessler","year":"2000","unstructured":"Kessler, D. A. Cancer and herbs. N. Engl. J. Med. 342, 1742\u20131743, https:\/\/doi.org\/10.1056\/nejm200006083422309 (2000).","journal-title":"N. Engl. J. Med."},{"key":"56394_CR20","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.285.21.2705","volume":"285","author":"BA Schwetz","year":"2001","unstructured":"Schwetz, B. A. Safety of aristolochic acid. JAMA 285, 2705\u20132705, https:\/\/doi.org\/10.1001\/jama.285.21.2705 (2001).","journal-title":"JAMA"},{"key":"56394_CR21","doi-asserted-by":"publisher","first-page":"569325","DOI":"10.1155\/2014\/569325","volume":"2014","author":"HY Yang","year":"2014","unstructured":"Yang, H. Y., Chen, P. C. & Wang, J. D. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. Biomed. Res. Int. 2014, 569325, https:\/\/doi.org\/10.1155\/2014\/569325 (2014).","journal-title":"Biomed. Res. Int."},{"key":"56394_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal, J. L., Cummins, S. & Gasparrini, A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int. J. Epidemiol. 46, 348\u2013355, https:\/\/doi.org\/10.1093\/ije\/dyw098 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"56394_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ije\/dyt092","volume":"42","author":"K Bhaskaran","year":"2013","unstructured":"Bhaskaran, K., Gasparrini, A., Hajat, S., Smeeth, L. & Armstrong, B. Time series regression studies in environmental epidemiology. Int. J. Epidemiol. 42, 1187\u20131195, https:\/\/doi.org\/10.1093\/ije\/dyt092 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"56394_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jjco\/hyu211","volume":"45","author":"CJ Chiang","year":"2015","unstructured":"Chiang, C. J. et al. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn. J. Clin. Oncol. 45, 291\u2013296, https:\/\/doi.org\/10.1093\/jjco\/hyu211 (2015).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"56394_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jfma.2019.01.012","volume":"118","author":"CJ Chiang","year":"2019","unstructured":"Chiang, C. J., Wang, Y. W. & Lee, W. C. Taiwan\u2019s nationwide cancer registry system of 40 years: past, present, and future. J. Formos. Med. Assoc. 118, 856\u2013858, https:\/\/doi.org\/10.1016\/j.jfma.2019.01.012 (2019).","journal-title":"J. Formos. Med. Assoc."},{"key":"56394_CR26","unstructured":"Fritz A. G. et al. International Classifi cation of Diseases for Oncology (ICD-O). 3rd edn. Geneva: World Health Organization (2000)."},{"key":"56394_CR27","unstructured":"Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Taiwan Cancer Registry Annual Report. Available at, https:\/\/www.hpa.gov.tw\/Pages\/List.aspx?nodeid=269 (Accessed: 22th July 2019)."},{"key":"56394_CR28","unstructured":"Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Taiwan Tobacco Control Annual Report 2015. Available at, https:\/\/www.hpa.gov.tw\/EngPages\/List.aspx?nodeid=1069 (Accessed: 22th July 2019)."},{"key":"56394_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12963-016-0109-x","volume":"14","author":"CY Chiang","year":"2016","unstructured":"Chiang, C. Y. & Chang, H. Y. A population study on the time trend of cigarette smoking, cessation, and exposure to secondhand smoking from 2001 to 2013 in Taiwan. Popul. Health Metr. 14, 38, https:\/\/doi.org\/10.1186\/s12963-016-0109-x (2016).","journal-title":"Popul. Health Metr."},{"key":"56394_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-3-13","volume":"3","author":"SC Hsieh","year":"2008","unstructured":"Hsieh, S. C., Lin, I. H., Tseng, W. L., Lee, C. H. & Wang, J. D. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin. Med. 3, 13, https:\/\/doi.org\/10.1186\/1749-8546-3-13 (2008).","journal-title":"Chin. Med."},{"key":"56394_CR31","unstructured":"National Cancer Institute. Surveillance, epidemiology and end results program. Multiple primary and histology coding rules. Bethesda, MD: National Cancer Institute (2007)."},{"key":"56394_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger, M. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63, 234\u2013241, https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033 (2013).","journal-title":"Eur. Urol."},{"key":"56394_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"WH Chow","year":"2010","unstructured":"Chow, W. H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 7, 245\u2013257, https:\/\/doi.org\/10.1038\/nrurol.2010.46 (2010).","journal-title":"Nat. Rev. Urol."},{"key":"56394_CR34","doi-asserted-by":"publisher","first-page":"77942","DOI":"10.18632\/oncotarget.18549","volume":"8","author":"QW Shaojing Zhang","year":"2017","unstructured":"Shaojing Zhang, Q. W. Juanjuan He. Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget 8, 77942\u201377956, https:\/\/doi.org\/10.18632\/oncotarget.18549 (2017).","journal-title":"Oncotarget"},{"key":"56394_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","volume":"24","author":"J Miyazaki","year":"2017","unstructured":"Miyazaki, J. & Nishiyama, H. Epidemiology of urothelial carcinoma. Int. J. Urol. 24, 730\u2013734, https:\/\/doi.org\/10.1111\/iju.13376 (2017).","journal-title":"Int. J. Urol."},{"key":"56394_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","volume":"17","author":"VM Arlt","year":"2002","unstructured":"Arlt, V. M., Stiborova, M. & H., H. S. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17, 265\u2013277, https:\/\/doi.org\/10.1093\/mutage\/17.4.265 (2002).","journal-title":"Mutagenesis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56394-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:58:52Z","timestamp":1671299932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56394-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56394"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56394-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19860"}}